Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-12-07

FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (Apotex Corp.)

View source ↗

Summary

The FDA approved Apotex Corp.'s original application for olopatadine hydrochloride, a generic antihistamine eye drop for allergic conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE HYDROCHLORIDE (olopatadine hydrochloride)

Snippet

ORIG AP for OLOPATADINE HYDROCHLORIDE (OLOPATADINE HYDROCHLORIDE)